Stocks
Intra-Cellular Therapies (ITCI) Net profit US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net profit, bln rub | ? | -147.7 | -227.0 | -284.1 | -256.3 | -139.7 | -86.4 | ||
| Changes by years, y/y, % | -5% | +54% | +25% | -10% | -45% | -2.1% | |||
Intra-Cellular Therapies. Net profit US GAAP, bln rub
Intra-Cellular Therapies. Net profit US GAAP, changes, %
Intra-Cellular Therapies. Net profit US GAAP, sum by quarters, bln rub
Intra-Cellular Therapies (ITCI) Net profit US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net profit, bln rub | ? | -24.3 | -28.6 | -15.2 | -16.2 | -26.3 | -86.4 | |
| Changes by years, y/y, % | -55% | -23% | -65% | -62% | +9% | |||
| Changes by quarters, q/q, % | -43% | +18% | -47% | +6% | +62% | |||
